December 05, 2016 SAN DIEGO–(BUSINESS WIRE)–Kyocera Medical Corporation, a leading manufacturer of implantable systems and advanced ceramic components, today announced it has received the U.S. Food and Drug Administration’s 510(k) clearance for its Initia® Total Hip System. Developed in collaboration with leading U.S. surgeons, the Initia Total Hip System features Kyocera Medical Corporation’s core technologies […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone